Neuroblastoma: When differentiation goes awry

Maged Zeineldin1, Anand G Patel2, Michael A Dyer3

  • 1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Neuron
|August 19, 2022
PubMed

Insights

Neuroblastoma, a childhood cancer, arises from arrested neural crest progenitor cells. Understanding this developmental arrest offers new strategies for neuroblastoma treatment.

Area of Science:

  • Pediatric Oncology
  • Developmental Biology
  • Cancer Genetics

Background:

  • Neuroblastoma is a significant cause of childhood cancer mortality.
  • Evidence suggests a link between differentiation arrest in neural crest-derived sympathoadrenal cells and neuroblastoma.
  • This developmental arrest model explains key disease characteristics like heterogeneity and regression.

Purpose of the Study:

  • To review the evidence supporting the hypothesis that arrested neural crest progenitor cells cause neuroblastoma.
  • To explore the clinical implications of this concept for disease management.

Main Methods:

  • Literature review and synthesis of existing data.
  • Analysis of developmental biology and cancer genetics research related to neuroblastoma.

Main Results:

  • Accumulated data strongly support the differentiation arrest model for neuroblastoma pathogenesis.
  • This model provides a unified explanation for diverse neuroblastoma features.

Conclusions:

  • Arrested neural crest-derived progenitor cells are a likely origin of neuroblastoma.
  • Targeting this developmental mechanism presents a promising avenue for novel therapeutic strategies.

Related Concept Videos